Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
HBIO Harvard Bioscience	$0.51 -2.8%	$0.39	$0.28 ▼ $3.60	$22.50M	1.56	3.10 million shs	656,151 shs
LIFE aTyr Pharma		$1.76	$1.08 ▼ $2.45	$131.12M	1.19	514,103 shs	269,400 shs
PACB Pacific Biosciences of California	$1.20 +1.7%	$1.13	$0.85 ▼ $2.72	$360.10M	2.1	9.67 million shs	7.31 million shs
TMO Thermo Fisher Scientific	$402.12 -3.2%	$416.80	$390.50 ▼ $627.88	$151.80B	0.78	1.93 million shs	2.38 million shs

Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
HBIO Harvard Bioscience	0.00%	+24.43%	+49.82%	-26.80%	-82.42%
LIFE aTyr Pharma	0.00%	0.00%	0.00%	0.00%	0.00%
PACB Pacific Biosciences of California	0.00%	+5.26%	+15.94%	-3.23%	-31.82%
TMO Thermo Fisher Scientific	0.00%	+0.03%	-2.43%	-22.57%	-29.71%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
HBIO Harvard Bioscience	3.8533 of 5 stars	3.3	2.0	0.0	4.5	2.1	1.7	0.6
LIFE aTyr Pharma	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
PACB Pacific Biosciences of California	2.0477 of 5 stars	3.3	3.0	0.0	0.0	1.6	0.0	1.3
TMO Thermo Fisher Scientific	4.9702 of 5 stars	4.4	3.0	2.5	4.1	3.5	2.5	1.9

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
HBIO Harvard Bioscience	2.50	Moderate Buy	$3.00	489.62% Upside
LIFE aTyr Pharma	0.00	N/A	N/A	N/A
PACB Pacific Biosciences of California	2.50	Moderate Buy	$2.13	77.60% Upside
TMO Thermo Fisher Scientific	2.80	Moderate Buy	$605.30	50.53% Upside

Current Analyst Ratings Breakdown

Latest LIFE, PACB, HBIO, and TMO Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
5/15/2025	PACB Pacific Biosciences of California	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$2.00 ➝ $1.25
5/15/2025	PACB Pacific Biosciences of California	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$1.80 ➝ $1.80
5/13/2025	HBIO Harvard Bioscience	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Speculative Buy ➝ Speculative Buy	$4.50 ➝ $3.00
4/29/2025	TMO Thermo Fisher Scientific	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$620.00 ➝ $470.00
4/25/2025	TMO Thermo Fisher Scientific	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Sector Perform ➝ Sector Perform	$650.00 ➝ $605.00
4/24/2025	TMO Thermo Fisher Scientific	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$651.00 ➝ $637.00
4/24/2025	TMO Thermo Fisher Scientific	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$715.00 ➝ $500.00
4/24/2025	TMO Thermo Fisher Scientific	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$665.00 ➝ $620.00
4/24/2025	TMO Thermo Fisher Scientific	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$585.00 ➝ $500.00
4/24/2025	TMO Thermo Fisher Scientific	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$580.00 ➝ $570.00
4/24/2025	TMO Thermo Fisher Scientific	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$603.00 ➝ $573.00

(Data available from 6/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
HBIO Harvard Bioscience	$91.40M	0.25	$0.10 per share	5.16	$1.71 per share	0.30
LIFE aTyr Pharma	$350K	0.00	N/A	N/A	$1.54 per share	0.00
PACB Pacific Biosciences of California	$152.36M	2.36	N/A	N/A	$2.62 per share	0.46
TMO Thermo Fisher Scientific	$42.90B	3.54	$22.45 per share	17.91	$129.54 per share	3.10

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
HBIO Harvard Bioscience	-$3.41M	-$1.32	N/A	∞	N/A	-14.57%	-4.64%	-2.40%	8/6/2025 (Estimated)
LIFE aTyr Pharma	-$50.39M	-$0.90	N/A	N/A	N/A	N/A	-56.92%	-43.87%	N/A
PACB Pacific Biosciences of California	-$308.65M	-$2.79	N/A	N/A	N/A	-200.40%	-42.89%	-14.77%	8/6/2025 (Estimated)
TMO Thermo Fisher Scientific	$6.34B	$17.05	24.33	15.73	2.99	14.78%	17.51%	8.52%	7/23/2025 (Estimated)

Latest LIFE, PACB, HBIO, and TMO Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
5/8/2025	Q1 2025	PACB Pacific Biosciences of California	-$0.19	-$0.15	+$0.04	-$1.44	$36.90 million	$37.15 million
4/23/2025	Q1 2025	TMO Thermo Fisher Scientific	$5.10	$5.15	+$0.05	$3.98	$10.23 billion	$10.36 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
HBIO Harvard Bioscience	N/A	N/A	N/A	N/A	N/A
LIFE aTyr Pharma	N/A	N/A	N/A	N/A	N/A
PACB Pacific Biosciences of California	N/A	N/A	N/A	N/A	N/A
TMO Thermo Fisher Scientific	$1.72	0.43%	N/A	10.09%	8 Years

Latest LIFE, PACB, HBIO, and TMO Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/21/2025	TMO Thermo Fisher Scientific	quarterly	$0.43	0.43%	6/13/2025	6/13/2025	7/15/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
HBIO Harvard Bioscience	0.52	2.06	0.91
LIFE aTyr Pharma	0.02	6.07	6.07
PACB Pacific Biosciences of California	1.97	9.74	8.64
TMO Thermo Fisher Scientific	0.59	1.66	1.29

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
HBIO Harvard Bioscience	80.87%
LIFE aTyr Pharma	61.72%
PACB Pacific Biosciences of California	N/A
TMO Thermo Fisher Scientific	89.23%

Insider Ownership

Company	Insider Ownership
HBIO Harvard Bioscience	9.50%
LIFE aTyr Pharma	3.70%
PACB Pacific Biosciences of California	2.50%
TMO Thermo Fisher Scientific	0.33%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
HBIO Harvard Bioscience	490	44.21 million	39.69 million	Optionable
LIFE aTyr Pharma	56	69.01 million	66.46 million	Optionable
PACB Pacific Biosciences of California	730	300.09 million	267.29 million	Optionable
TMO Thermo Fisher Scientific	130,000	377.49 million	381.20 million	Optionable

LIFE, PACB, HBIO, and TMO Headlines

Recent News About These Companies

October 17th Options Now Available For Thermo Fisher Scientific (TMO)

June 15 at 8:02 PM | nasdaq.com

Biotech Stocks To Follow Today - June 15th

June 15 at 2:10 PM | marketbeat.com

Mn Services Vermogensbeheer B.V. Has $70.81 Million Stock Position in Thermo Fisher Scientific Inc. (NYSE:TMO)

June 15 at 9:02 AM | marketbeat.com

Fairvoy Private Wealth LLC Raises Stake in Thermo Fisher Scientific Inc. (NYSE:TMO)

June 15 at 8:53 AM | marketbeat.com

James Hambro & Partners LLP Purchases 12,219 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO)

June 15 at 8:00 AM | marketbeat.com

Compass Capital Management Inc. Grows Position in Thermo Fisher Scientific Inc. (NYSE:TMO)

June 15 at 7:43 AM | marketbeat.com

Sfm LLC Takes $1.52 Million Position in Thermo Fisher Scientific Inc. (NYSE:TMO)

June 15 at 7:43 AM | marketbeat.com

MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH Raises Stock Holdings in Thermo Fisher Scientific Inc. (NYSE:TMO)

June 15 at 7:21 AM | marketbeat.com

Dohj LLC Buys New Holdings in Thermo Fisher Scientific Inc. (NYSE:TMO)

June 15 at 6:47 AM | marketbeat.com

Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Sold by Stock Yards Bank & Trust Co.

June 15 at 5:19 AM | marketbeat.com

Thermo Fisher (TMO) Gets a Buy from TD Cowen

June 14 at 10:58 PM | theglobeandmail.com

Top Biotech Stocks To Follow Today - June 14th

June 14 at 2:04 PM | marketbeat.com

Jackson Square Capital LLC Sells 685 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO)

June 14 at 6:54 AM | marketbeat.com

Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Bought by New England Research & Management Inc.

June 14 at 6:28 AM | marketbeat.com

Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Sold by SG Americas Securities LLC

June 14 at 4:06 AM | marketbeat.com

Thermo Fisher Scientific Explores Diagnostics Exit Amid mRNA Expansion S&P 500

June 13 at 4:53 PM | kalkinemedia.com

Thermo Fisher Scientific (NYSE:TMO) Explores US$4 Billion Diagnostics Sale, Expands mRNA Collaboration

June 13 at 4:53 PM | finance.yahoo.com

Top Biotech Stocks To Consider - June 13th

June 13 at 2:15 PM | marketbeat.com

Report: Biotech Research Firm Thermo Fisher Considers Selling Diagnostics Business

June 13 at 1:27 PM | pymnts.com

Report: Biotech Research Firm Thermo Fisher Considers Selling Diagnostics Business

June 13 at 1:05 PM | pymnts.com

Thermo Fisher Stock Hurt by Macroeconomic Woes, Tough Competition

June 13 at 12:26 PM | zacks.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

LIFE, PACB, HBIO, and TMO Company Descriptions

Harvard Bioscience NASDAQ:HBIO

$0.51 -0.01 (-2.79%)

Closing price 06/13/2025 04:00 PM Eastern

Extended Trading

$0.51 0.00 (-0.35%)

As of 06/13/2025 07:57 PM Eastern

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the United States and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings. It also provides preclinical products that includes platform to assess physiological data from organisms for research, drug discovery, and drug development services comprising implantable and externally worn telemetry systems for use in research to collect cardiovascular, central nervous system, respiratory, and metabolic data; behavioral products; isolated organ and surgical products, instruments and accessories for tissue, and organ-based lab research, including surgical products, infusion systems, and behavior research systems; turn-key respiratory system solutions, including plethysmograph chambers, data acquisition hardware, physiological signal analysis software, and final report generation; inhalation and exposure systems; and GLP-capable data acquisition and analysis systems. The company markets its products through sales organizations, websites, and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories; and contract research organizations and academic labs. It primarily sells its products under Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab brands. Harvard Bioscience, Inc. was founded in 1901 and is based in Holliston, Massachusetts.

aTyr Pharma NASDAQ:LIFE

aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. Its lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase III clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for treatment of other interstitial lung diseases (ILDs), such as chronic hypersensitivity pneumonitis and connective tissue disease related ILD. The company is developing ATYR0101, a fusion protein derived from a domain of aspartyl-tRNA synthetase that is in preclinical development for the treatment of fibrosis; and ATYR0750, a domain of alanyl-tRNA synthetase for the treatment of liver disorders. It has collaboration and license agreement with Kyorin Pharmaceutical Co., Ltd. for the development and commercialization of efzofitimod for ILDs in Japan. aTyr Pharma, Inc. was incorporated in 2005 and is headquartered in San Diego, California.

Pacific Biosciences of California NASDAQ:PACB

$1.20 +0.02 (+1.69%)

Closing price 06/13/2025 04:00 PM Eastern

Extended Trading

$1.17 -0.03 (-2.50%)

As of 06/13/2025 07:58 PM Eastern

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solution to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-red sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. In addition, it provides revio system + sequel systems which conduct, monitor, and analyze single-molecule biochemical reactions in real time; SBB short-read sequencing; onso instrument conducts, monitors, and analyzes SBB biochemical reactions; and SBB consumable, including flow cells, clustering, and sequencing reagent kits. The company serves academic and governmental research institutions; commercial testing and service laboratories; genome centers; public health labs, hospitals and clinical research institutes, and contract research organizations; pharmaceutical companies; and agricultural companies. It markets its products through a sales force and distribution partners in Asia, Australia, Europe, the Middle East, Africa, and Latin America. It has a development and commercialization agreement with Invitae Corporation; and a collaboration with Radboud University Medical to explore genetic causes of rare and genetic diseases. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.

Thermo Fisher Scientific NYSE:TMO

$402.12 -13.21 (-3.18%)

Closing price 06/13/2025 03:59 PM Eastern

Extended Trading

$402.50 +0.38 (+0.10%)

As of 06/13/2025 07:59 PM Eastern

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time